AW
SRPT icon

Avion Wealth’s Sarepta Therapeutics SRPT Stock Holding History

Avion Wealth’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5K Hold
300
– – ﹤0.01% 806
2026
Q1 		$6K Hold
300
– – ﹤0.01% 626
2025
Q4 		$6K Buy
300
+272
+971% +$5.73K ﹤0.01% 635
2025
Q3 		$0 Buy
28
+20
+250% +$357 ﹤0.01% 1534
2025
Q2 		$0 Buy
8
+2
+33% +$85 ﹤0.01% 1583
2025
Q1 		$0 Buy
+6
New +$632 ﹤0.01% 1341
2024
Q4 		– Sell
-12
Closed -$1K – 1265
2024
Q3 		$1K Buy
12
+4
+50% +$553 ﹤0.01% 906
2024
Q2 		$1K Buy
+8
New +$1.03K ﹤0.01% 814
2023
Q4 		– Sell
-4
Closed – – 1326
2023
Q3 		$0 Buy
+4
New +$452 ﹤0.01% 1174

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Avion Wealth's SRPT Position: Q2 2026 in Review

Avion Wealth held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 300 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

Avion Wealth first reported a position in SRPT in Q3 2023 and has held it in 9 quarters since. The position peaked at $6K in Q1 2026. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Avion Wealth held 300 shares of Sarepta Therapeutics worth $5K as of Q2 2026.
  • Avion Wealth left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #806 holding.
  • Avion Wealth first reported a position in Sarepta Therapeutics in Q3 2023 and has held it in 9 quarters since.
  • Avion Wealth's Sarepta Therapeutics position peaked at $6K in Q1 2026.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.